ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline

Main Recommendations Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before endoscopic retrograde cholangiopancreatography (ERCP) in all patients without contraindications to nonsteroidal anti-inflammatory drug administration. Strong recommendation, moderate quality evidence. 2 ESGE recommends prophylactic pancreatic stenting in selected patients at high risk for post-ERCP pancreatitis (inadvertent guidewire insertion/opacification of the pancreatic duct, double-guidewire cannulation). Strong recommendation, moderate quality evidence. 3 ESGE suggests against routine endoscopic biliary sphincterotomy before the insertion of a single plastic stent or an uncovered/partially covered self-expandable metal stent for relief of biliary obstruction. Weak recommendation, moderate quality evidence. 4 ESGE recommends against the routine use of antibiotic prophylaxis before ERCP. Strong recommendation, moderate quality evidence. 5 ESGE suggests antibiotic prophylaxis before ERCP in the case of anticipated incomplete biliary drainage, for severely immunocompromised patients, and when performing cholangioscopy. Weak recommendation, moderate quality evidence. 6 ESGE suggests tests of coagulation are not routinely required prior to ERCP for patients who are not on anticoagulants and not jaundiced. Weak recommendation, low quality evidence. Treatment 7 ESGE suggests against salvage pancreatic stenting in patients with post-ERCP pancreatitis. Weak recommendation, low quality evidence. 8 ESGE suggests temporary placement of a biliary fully covered self-expandable metal stent for post-sphincterotomy bleeding refractory to standard hemostatic modalities. Weak recommendation, low quality evidence. 9 ESGE suggests to evaluate patients with post-ERCP cholangitis by abdominal ultrasonography or computed tomography (CT) scan and, in the absence of improvement with conservative therapy, to consider repeat ERCP. A bile sample should be collected for microbiological examination during repeat ERCP. Weak recommendation, low quality evidence.

[1]  Dong Wook Lee,et al.  Impact of Hospital Volume and the Experience of Endoscopist on Adverse Events Related to Endoscopic Retrograde Cholangiopancreatography: A Prospective Observational Study , 2020, Gut and liver.

[2]  X. Wan,et al.  Serum lipase as a biomarker for early prediction and diagnosis of post-endoscopic retrograde cholangiopancreatography pancreatitis , 2019, Irish Journal of Medical Science (1971 -).

[3]  R. Malekzadeh,et al.  Pharmacological prophylaxis versus pancreatic duct stenting plus pharmacological prophylaxis for prevention of post-ERCP pancreatitis in high risk patients: a randomized trial , 2019, Endoscopy.

[4]  D. Fan,et al.  Rectal Indomethacin and Spraying of Duodenal Papilla With Epinephrine Increases Risk of Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography. , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  A. Hapfelmeier,et al.  Pancreatic stenting to prevent post-ERCP pancreatitis: a randomized multicenter trial , 2019, Endoscopy International Open.

[6]  Katherine Fennedy,et al.  Moderate , 2019, Definitions.

[7]  H. Goyal,et al.  Duodenoscope-Associated Infections: Update on an Emerging Problem , 2019, Digestive Diseases and Sciences.

[8]  H. Ohira,et al.  Pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis , 2019, World Journal of Meta-Analysis.

[9]  P. Varjú,et al.  Transpancreatic Sphincterotomy Is Effective and Safe in Expert Hands on the Short Term , 2019, Digestive Diseases and Sciences.

[10]  M. Matsubara,et al.  Combination of Diclofenac and Sublingual Nitrates Is Superior to Diclofenac Alone in Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography. , 2019, Gastroenterology.

[11]  T. Ponchon,et al.  Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline , 2019, Endoscopy.

[12]  M. Abdelfatah,et al.  Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Single Versus Dual Prophylactic Modalities. , 2019, Pancreas.

[13]  W. Bernardo,et al.  Nonsteroidal anti-inflammatory drugs versus placebo for post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and meta-analysis , 2019, Endoscopy International Open.

[14]  J. Liisanantti,et al.  Prophylactic pancreatic duct stenting in severe acute necrotizing pancreatitis: a prospective randomized study , 2019, Endoscopy.

[15]  Ming-Hseng Tseng,et al.  Major bleeding risk of endoscopic sphincterotomy versus endoscopic papillary balloon dilatation in hemodialysis patients , 2019, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[16]  D. Srivastava,et al.  Complications of endoscopic retrograde cholangiopancreatography: an imaging review , 2019, Abdominal Radiology.

[17]  E. van Geenen,et al.  The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteria , 2019, United European gastroenterology journal.

[18]  Shu-Ling Wang,et al.  Endocut Versus Conventional Blended Electrosurgical Current for Endoscopic Biliary Sphincterotomy: A Meta-Analysis of Complications , 2019, Digestive Diseases and Sciences.

[19]  A. Kurita,et al.  Comparison between a rotatable sphincterotome and a conventional sphincterotome for selective bile duct cannulation , 2019, Endoscopy.

[20]  E. Parlak,et al.  Wire-guided cannulation over a pancreatic stent method increases the need for needle-knife precutting ın patients with difficult biliary cannulations. , 2019, Gastrointestinal endoscopy.

[21]  Vikesh K. Singh,et al.  A Randomized Trial of Topical Epinephrine and Rectal Indomethacin for Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients , 2019, The American journal of gastroenterology.

[22]  N. Enomoto,et al.  Risk factors for perforation during endoscopic retrograde cholangiopancreatography in post-reconstruction intestinal tract , 2019, World journal of clinical cases.

[23]  Dong Wook Lee,et al.  Risk factor of bleeding after endoscopic sphincterotomy in average risk patients , 2019, Surgical Endoscopy.

[24]  M. Friedrich-Rust,et al.  Prolonged retention of prophylactic pancreatic stents is not associated with increased complications. , 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[25]  L. Fuccio,et al.  Endoscopic biliary self-expandable metallic stent in malignant biliary obstruction with or without sphincterotomy: systematic review and meta-analysis , 2019, Endoscopy International Open.

[26]  J. Rey,et al.  Reprocessing of flexible endoscopes and endoscopic accessories used in gastrointestinal endoscopy: Position Statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA) – Update 2018 , 2018, Endoscopy.

[27]  H. Sayles,et al.  Endoscopic retrograde cholangiopancreatography in cirrhosis - a systematic review and meta-analysis focused on adverse events , 2018, World journal of gastrointestinal endoscopy.

[28]  B. Petersen,et al.  End-stage renal disease is associated with increased post endoscopic retrograde cholangiopancreatography adverse events in hospitalized patients , 2018, World journal of gastroenterology.

[29]  T. Shah,et al.  Significant infections in liver transplant recipients undergoing endoscopic retrograde cholangiography are few and unaffected by prophylactic antibiotics. , 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[30]  A. Trindade,et al.  Periampullary Diverticula and ERCP Outcomes: A Systematic Review and Meta-Analysis , 2018, Digestive Diseases and Sciences.

[31]  X. Zou,et al.  Modified prophylactic 5-fr pancreatic duct stent enhances the rate of spontaneous dislodgement: A multicenter randomized controlled trial , 2018, United European gastroenterology journal.

[32]  S. Chandra,et al.  Endoscopic Retrograde Cholangio-Pancreatography-Obtained Bile Culture Can Guide Antibiotic Therapy in Acute Cholangitis , 2018, Digestive Diseases.

[33]  Andrew A. White,et al.  Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper , 2018, Allergy.

[34]  T. Muniraj,et al.  Cannabis Use Is Associated With Increased Risk of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: Analysis of the US Nationwide Inpatient Sample Database, 2004–2014 , 2018, Pancreas.

[35]  Yuan-jin Huang,et al.  Nonsteroidal Anti-inflammatory Drugs for Endoscopic Retrograde Cholangiopancreatography Postoperative Pancreatitis Prevention: a Systematic Review and Meta-analysis , 2018, Journal of Gastrointestinal Surgery.

[36]  Mahsa Khodadoostan,et al.  Combination of diclofenac and aggressive hydration for the prevention of post-ERCP pancreatitis , 2018, Gastroenterology and hepatology from bed to bench.

[37]  W. Meng,et al.  Early precut sphincterotomy does not increase the risk of adverse events for patients with difficult biliary access , 2018, Medicine.

[38]  W. Silverman,et al.  Evaluation of Biliary Bacterial Resistance in Patients with Frequent Biliary Instrumentation, One Size Does Not Fit All , 2018, Digestive Diseases and Sciences.

[39]  W. Bernardo,et al.  Comparison between endoscopic sphincterotomy vs endoscopic sphincterotomy associated with balloon dilation for removal of bile duct stones: A systematic review and meta-analysis based on randomized controlled trials , 2018, World journal of gastrointestinal endoscopy.

[40]  C. Hassan,et al.  Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017 , 2018, Endoscopy.

[41]  N. Lu,et al.  Assessing Quality of Precut Sphincterotomy in Patients With Difficult Biliary Access: An Updated Meta-analysis of Randomized Controlled Trials , 2018, Journal of clinical gastroenterology.

[42]  Wade M. Lee,et al.  Role of Cholecystectomy After Endoscopic Sphincterotomy in the Management of Choledocholithiasis in High-risk Patients: A Systematic Review and Meta-Analysis , 2018, Journal of clinical gastroenterology.

[43]  F. Bazzoli,et al.  Comparison of Efficacy and Safety of 4 Combinations of Laparoscopic and Intraoperative Techniques for Management of Gallstone Disease With Biliary Duct Calculi: A Systematic Review and Network Meta-analysis , 2018, JAMA surgery.

[44]  Yunxiao Lyu,et al.  What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials , 2018, BMC Gastroenterology.

[45]  H. Ohira,et al.  Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail , 2018, World journal of gastroenterology.

[46]  M. Sattari,et al.  Serum amylase and lipase levels for prediction of postendoscopic retrograde cholangiopancreatography pancreatitis , 2018, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[47]  T. Tong,et al.  Prevention of post‐sphincterotomy bleeding by proton pump inhibitor: A randomized controlled trial , 2018, Journal of digestive diseases.

[48]  Xianzhong Xiao,et al.  Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis. , 2018, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[49]  J. Lau,et al.  The impact of wire caliber on ERCP outcomes: a multicenter randomized controlled trial of 0.025-inch and 0.035-inch guidewires. , 2018, Gastrointestinal endoscopy.

[50]  Kook-Hyun Kim,et al.  Safety and Efficacy of Endoscopic Retrograde Cholangiopancreatography for Choledocholithiasis in Long-Term Dialysis: A Propensity Score Analysis , 2018, Digestive Diseases and Sciences.

[51]  J. Si,et al.  Rectal Indomethacin Is Protective against Pancreatitis after Endoscopic Retrograde Cholangiopancreatography: Systematic Review and Meta-Analysis , 2018, Gastroenterology research and practice.

[52]  Natsuki Kawamitsu,et al.  Hemodialysis is a strong risk factor for post-endoscopic sphincterotomy bleeding in patients with choledocholithiasis , 2018, Endoscopy International Open.

[53]  Dong Wook Kim,et al.  A nationwide population-based study of common bile duct stone recurrence after endoscopic stone removal in Korea , 2018, Journal of Gastroenterology.

[54]  R. Garg,et al.  Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis , 2018, Indian Journal of Gastroenterology.

[55]  R. Meister,et al.  Safety of diclofenac use during early pregnancy: A prospective observational cohort study. , 2018, Reproductive toxicology.

[56]  J. Ryu,et al.  Utility of serum phosphate as a marker for predicting the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis , 2018, United European gastroenterology journal.

[57]  Esther Olunu,et al.  Stevens - Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities , 2018, Open access Macedonian journal of medical sciences.

[58]  A. Barkun,et al.  Rectal Indomethacin Prevents Moderate to Severe Post-ERCP Pancreatitis and Death and Should Be Used Before the Procedure: A Meta-Analysis of Aggregate Subgroup Data , 2018, Journal of the Canadian Association of Gastroenterology.

[59]  V. Kaul,et al.  A novel, duodenoscope-friendly endoscopic clip for treating massive upper-GI bleeding secondary to a Dieulafoy lesion , 2018, VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy.

[60]  Don Haeng Lee,et al.  Effectiveness of a novel highly flexible‐tip guidewire on selective biliary cannulation compared to conventional guidewire: Randomized controlled study , 2018, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[61]  Bin Lu,et al.  Use of NSAIDs via the Rectal Route for the Prevention of Pancreatitis after ERCP in All-Risk Patients: An Updated Meta-Analysis , 2018, Gastroenterology research and practice.

[62]  T. Ling,et al.  Risk factor analysis of post-ERCP cholangitis: A single-center experience. , 2018, Hepatobiliary & pancreatic diseases international : HBPD INT.

[63]  R. Kiesslich,et al.  Acute sedation-associated complications in GI endoscopy (ProSed 2 Study): results from the prospective multicentre electronic registry of sedation-associated complications , 2018, Gut.

[64]  D. Gouma,et al.  Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos) , 2018, Journal of hepato-biliary-pancreatic sciences.

[65]  D. Gouma,et al.  Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos) , 2018, Journal of hepato-biliary-pancreatic sciences.

[66]  Liang-an Chen,et al.  Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study , 2017, Antimicrobial Resistance & Infection Control.

[67]  W. Paik,et al.  Aggressive intravenous hydration with lactated Ringer’s solution for prevention of post-ERCP pancreatitis: a prospective randomized multicenter clinical trial , 2017, Endoscopy.

[68]  S. Sherman,et al.  Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents , 2017, Gut and liver.

[69]  R. Keswani,et al.  Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta‐analysis , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[70]  M. Kelly,et al.  A systematic review of the management and outcome of ERCP related duodenal perforations using a standardized classification system. , 2017, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[71]  J. Hwang,et al.  Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels , 2017, Journal of Korean medical science.

[72]  P. Fan,et al.  Rectal nonsteroidal anti-inflammatory drugs administration is effective for the prevention of post-ERCP pancreatitis: An updated meta-analysis of randomized controlled trials. , 2017, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[73]  N. Lu,et al.  The Efficiency of Aggressive Hydration With Lactated Ringer Solution for the Prevention of Post-ERCP Pancreatitis: A Systematic Review and Meta-analysis , 2017, Journal of clinical gastroenterology.

[74]  O. Voștinaru Adverse Effects and Drug Interactions of the Non‐Steroidal Anti‐Inflammatory Drugs , 2017 .

[75]  K. Zhu,et al.  Prophylactic ulinastatin administration for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis , 2017, Experimental and therapeutic medicine.

[76]  U. Navaneethan,et al.  New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis , 2017, Endoscopy International Open.

[77]  Tae Hyeon Kim,et al.  Endoclip therapy of post-sphincterotomy bleeding using a transparent cap-fitted forward-viewing gastroscope , 2017, Surgical Endoscopy.

[78]  D. Faigel,et al.  International Normalized Ratio Does Not Predict Gastrointestinal Bleeding After Endoscopic Retrograde Cholangiopancreatography in Patients With Cirrhosis , 2017, Gastroenterology research.

[79]  S. Shih,et al.  Clinical endoscopic management and outcome of post-endoscopic sphincterotomy bleeding , 2017, PloS one.

[80]  S. Ikarashi,et al.  Factors associated with delayed hemorrhage after endoscopic sphincterotomy: Japanese large single-center experience , 2017, Journal of Gastroenterology.

[81]  J. Gaughan,et al.  Lactated Ringer's solution in combination with rectal indomethacin for prevention of post-ERCP pancreatitis and readmission: a prospective randomized, double-blinded, placebo-controlled trial. , 2017, Gastrointestinal endoscopy.

[82]  S. Varadarajulu,et al.  Prophylactic rectal indomethacin may be ineffective for preventing post‐endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta‐analysis , 2017, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[83]  Peizhu Su,et al.  Rectal NSAIDs in the prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis in unselected patients: Systematic review and meta‐analysis , 2017, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[84]  Q. Hu,et al.  Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis , 2017, Scientific Reports.

[85]  G. Lahat,et al.  Management of endoscopic retrograde cholangiopancreatography–related perforations: Experience of a tertiary center , 2017, Surgery.

[86]  Zhenhua Zhu,et al.  How to select patients and timing for rectal indomethacin to prevent post-ERCP pancreatitis: a systematic review and meta-analysis , 2017, BMC Gastroenterology.

[87]  J. Vargo,et al.  Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis: a meta-analysis , 2017, Endoscopy International Open.

[88]  K. Thomopoulos,et al.  Recurrence of choledocholithiasis following endoscopic bile duct clearance: Long term results and factors associated with recurrent bile duct stones , 2017, World journal of gastrointestinal endoscopy.

[89]  F. Klebl,et al.  Prophylaxis of post-ERC infectious complications in patients with biliary obstruction by adding antimicrobial agents into ERC contrast media- a single center retrospective study , 2017, BMC Gastroenterology.

[90]  P. Moayyedi,et al.  Double-guidewire technique in difficult biliary cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis , 2016, Endoscopy.

[91]  Xiao-fei Tong,et al.  Role of Somatostatin in Preventing Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis: An Update Meta-analysis , 2016, Front. Pharmacol..

[92]  J. Cochrane,et al.  Comparing endoscopic intervention against fully covered self-expanding metal stent placement for post-endoscopic sphincterotomy bleed (CEASE Study) , 2016, Endoscopy International Open.

[93]  A. El Nakeeb,et al.  Post-endoscopic retrograde cholangiopancreatography pancreatitis: Risk factors and predictors of severity , 2016, World journal of gastrointestinal endoscopy.

[94]  R. Kumar,et al.  Guidelines for the management of Stevens–Johnson syndrome/toxic epidermal necrolysis: An Indian perspective , 2016, Indian journal of dermatology, venereology and leprology.

[95]  S. Kim,et al.  A Randomized Comparative Study of 24- and 6-Hour Infusion of Nafamostat Mesilate for the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective Randomized Comparison Trial , 2016, Pancreas.

[96]  M. Bulajic,et al.  Endoscopic and pharmacological treatment for prophylaxis against postendoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis and systematic review , 2016, European journal of gastroenterology & hepatology.

[97]  M. Dadgarmoghaddam,et al.  Prophylactic Effect of Rectal Indomethacin Administration, with and without Intravenous Hydration, on Development of Endoscopic Retrograde Cholangiopancreatography Pancreatitis Episodes: A Randomized Clinical Trial. , 2016, Archives of Iranian medicine.

[98]  C. Hassan,et al.  Papillary cannulation and sphincterotomy techniques at ERCP: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline , 2016, Endoscopy.

[99]  D. Fan,et al.  Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trial , 2016, The Lancet.

[100]  J. Magalhães,et al.  Sa1194 Impact of Intensive Hydration on the Incidence of Post-ERCP Pancreatitis: Double-Blinded Randomized Controlled Trial , 2016 .

[101]  B. Lacy,et al.  Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients. , 2016, Gastroenterology.

[102]  N. Pausawasdi,et al.  1061 A Randomized, Controlled Trial of Aggressive Fluid Hydration for the Prevention of Post-ERCP Pancreatitis , 2016 .

[103]  Cheng-Hui Lin,et al.  Predictors of re-bleeding after endoscopic hemostasis for delayed post-endoscopic sphincterotomy bleeding. , 2016, World journal of gastroenterology.

[104]  Hajime Sato,et al.  Prophylactic Efficacy of 3- or 5-cm Pancreatic Stents for Preventing Post-ERCP Pancreatitis: A Prospective, Randomized Trial , 2016, Journal of clinical gastroenterology.

[105]  J. Hodson,et al.  Performance of the revised Atlanta and determinant‐based classifications for severity in acute pancreatitis , 2016, The British journal of surgery.

[106]  Subhas Banerjee,et al.  Prospective evaluation of bacteremia rates and infectious complications among patients undergoing single-operator choledochoscopy during ERCP , 2016, Endoscopy.

[107]  E. Knight,et al.  Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines , 2016, Gut.

[108]  Zi-fang Song,et al.  Covered versus Uncovered Self-Expandable Metal Stents for Managing Malignant Distal Biliary Obstruction: A Meta-Analysis , 2016, PloS one.

[109]  C. Hassan,et al.  Non-anesthesiologist administration of propofol for gastrointestinal endoscopy: European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates Guideline – Updated June 2015 , 2015, Endoscopy.

[110]  Wen S. Lei,et al.  Prophylactic Effect of Somatostatin in Preventing Post-ERCP Pancreatitis: An Updated Meta-Analysis , 2015, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

[111]  F. Liu,et al.  Cap-assisted hemoclip application with forward-viewing endoscope for hemorrhage induced by endoscopic sphincterotomy: a prospective case series study , 2015, BMC Gastroenterology.

[112]  M. Bourke,et al.  Early Precut Sphincterotomy Does Not Increase Risk During Endoscopic Retrograde Cholangiopancreatography in Patients With Difficult Biliary Access: A Meta-analysis of Randomized Controlled Trials. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[113]  Prashant U. Titare,et al.  A STUDY OF DIAGNOSTIC ACCURACY AND UTILITY OF ULTRASOUND IN THE ASSESSMENT OF BILIARY STENT , 2015 .

[114]  M. Khoshbaten,et al.  Aggressive hydration with Lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial , 2015, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[115]  F. Zhang,et al.  Risk factors for post-ERCP pancreatitis: A systematic review and meta-analysis. , 2015, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[116]  T. Rustagi,et al.  Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Systematic Review and Meta-analysis , 2015, Pancreas.

[117]  P. Cotton,et al.  Incidence and predictors of post-ERCP pancreatitis in patients with suspected sphincter of Oddi dysfunction undergoing biliary or dual sphincterotomy: results from the EPISOD prospective multicenter randomized sham-controlled study , 2015, Endoscopy.

[118]  A. Oto,et al.  Resolution of pneumobilia as a predictor of biliary stent occlusion. , 2015, Clinical imaging.

[119]  Jun-bo Qian,et al.  Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis. , 2015, World journal of gastroenterology.

[120]  A. Ferrari,et al.  Management of liver transplantation biliary stricture: Results from a tertiary hospital. , 2015, World journal of gastrointestinal endoscopy.

[121]  U. Arnelo,et al.  The role of antibiotic prophylaxis in routine endoscopic retrograde cholangiopancreatography investigations as assessed prospectively in a nationwide study cohort , 2015, Scandinavian journal of gastroenterology.

[122]  Rong Wan,et al.  Nafamostat Mesilate for Prevention of Post-ERCP Pancreatitis: A Meta-analysis of Prospective, Randomized, Controlled Trials , 2015, Pancreas.

[123]  Palita Chuankrerkkul Mo1411 Aggressive Lactated Ringer's Solution for Prevention of Post ERCP Pancreatitis (Preliminary Data of a Prospective Randomized Trial) , 2015 .

[124]  Wei Huang,et al.  Rectal indomethacin for the prevention of post-ERCP pancreatitis: A meta-analysis of randomized controlled trials. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[125]  F. Ateş,et al.  Air cholangiogram is not sufficent to detect common bile duct stones during ERCP. , 2015, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.

[126]  U. Navaneethan,et al.  Precut sphincterotomy: efficacy for ductal access and the risk of adverse events. , 2015, Gastrointestinal endoscopy.

[127]  R. Bianco,et al.  Cross-sectional imaging of common and unusual complications after endoscopic retrograde cholangiopancreatography , 2015, Insights into Imaging.

[128]  J. Lau,et al.  Endoscopic Sphincterotomy with Large Balloon Dilation versus Endoscopic Sphincterotomy for Bile Duct Stones: A Systematic Review and Meta-Analysis , 2015, BioMed research international.

[129]  U. Navaneethan,et al.  ERCP-related adverse events in patients with primary sclerosing cholangitis. , 2015, Gastrointestinal endoscopy.

[130]  Yu Bai,et al.  Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial , 2015, Endoscopy.

[131]  M. Hiyoshi,et al.  Randomized Controlled Trial for Efficacy of Nafamostat Mesilate in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis , 2014, Pancreas.

[132]  T. Voiosu,et al.  Antibiotic Prophylaxis Prior to Elective ERCP Does Not Alter Cholangitis Rates or Shorten Hospital Stay: Results of an Observational Prospective Study of 138 Consecutive ERCPS. , 2014, Maedica.

[133]  N. Solymosi,et al.  Does Rectal Indomethacin Given for Prevention of Post-ERCP Pancreatitis Increase Bleeding After Biliary Endoscopic Sphincterotomy or Cardiovascular Mortality? , 2014, Medicine.

[134]  M. Stechman,et al.  Routine coagulation screening is an unnecessary step prior to ERCP in patients without biochemical evidence of jaundice: a cross-centre study. , 2014, International Journal of Surgery.

[135]  K. Chayama,et al.  Antibiotic prophylaxis for endoscopic retrograde chlangiopancreatography increases the detection rate of drug‐resistant bacteria in bile , 2014, Journal of hepato-biliary-pancreatic sciences.

[136]  Ursula A. Pritham,et al.  Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse. , 2014, Journal of obstetric, gynecologic, and neonatal nursing : JOGNN.

[137]  C. Hassan,et al.  Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Updated June 2014 , 2014, Endoscopy.

[138]  W. Laleman,et al.  Embolization of post-biliary sphincterotomy bleeding refractory to medical and endoscopic therapy: technical results, clinical efficacy and predictors of outcome , 2014, European Radiology.

[139]  C. Hassan,et al.  Diagnosis and management of iatrogenic endoscopic perforations: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement , 2014, Endoscopy.

[140]  Qing-Qing Shi,et al.  Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis. , 2014, World journal of gastroenterology.

[141]  A. Asgari,et al.  A Randomized Trial of Rectal Indomethacin and Sublingual Nitrates to Prevent Post-ERCP Pancreatitis , 2014, The American Journal of Gastroenterology.

[142]  B. Han,et al.  Rectal NSAIDs for the prevention of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials. , 2014, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.

[143]  H. Maguchi,et al.  Endoscopic removal technique of migrated pancreatic plastic stents , 2014, Journal of hepato-biliary-pancreatic sciences.

[144]  U. Arnelo,et al.  Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy (SADE) in 907 ERCPs , 2014, Scandinavian journal of gastroenterology.

[145]  Yue Li,et al.  Risk factors for post-ERCP pancreatitis: a systematic review of clinical trials with a large sample size in the past 10 years , 2014, European Journal of Medical Research.

[146]  Vikesh K. Singh,et al.  5-Fr vs. 3-Fr pancreatic stents for the prevention of post-ERCP pancreatitis in high-risk patients: a systematic review and network meta-analysis , 2014, Endoscopy.

[147]  Dan Liu,et al.  Endoscopic papillary large balloon dilation vs endoscopic sphincterotomy for retrieval of common bile duct stones: a meta-analysis. , 2014, World journal of gastroenterology.

[148]  M. Esmadi,et al.  The Effect of Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-Analysis , 2014, Pancreas.

[149]  V. Wadhwa,et al.  A Meta-Analysis on the Role of Rectal Diclofenac and Indomethacin in the Prevention of Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis , 2014, Pancreas.

[150]  T. Joh,et al.  Feasibility of endoscopic retrograde cholangiopancreatography‐related procedures in hemodialysis patients , 2014, Journal of gastroenterology and hepatology.

[151]  H. Yuhara,et al.  Pharmacologic prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis: protease inhibitors and NSAIDs in a meta-analysis , 2014, Journal of Gastroenterology.

[152]  L. Laine,et al.  Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[153]  M. Shiono,et al.  Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis , 2014, Journal of Gastroenterology.

[154]  S. Hutfless,et al.  Systematic review with network meta‐analysis: pharmacological prophylaxis against post‐ERCP pancreatitis , 2013, Alimentary pharmacology & therapeutics.

[155]  A. Barkun,et al.  Meta‐analysis: rectal indomethacin for the prevention of post‐ERCP pancreatitis , 2013, Alimentary pharmacology & therapeutics.

[156]  Youming Li,et al.  Glyceryl Trinitrate for Prevention of Post-ERCP Pancreatitis and Improve the Rate of Cannulation: A Meta-Analysis of Prospective, Randomized, Controlled Trials , 2013, PloS one.

[157]  E. Parlak,et al.  Factors affecting the success of endoscopic treatment of sphincterotomy bleeding. , 2013, Clinics and research in hepatology and gastroenterology.

[158]  X. Calvet,et al.  How and When Should NSAIDs Be Used for Preventing Post-ERCP Pancreatitis? A Systematic Review and Meta-Analysis , 2013, PloS one.

[159]  M. Freeman,et al.  Urgent ERCP with pancreatic stent placement or replacement for salvage of post-ERCP pancreatitis , 2014, Endoscopy.

[160]  Zhen Wang,et al.  Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[161]  Yang Bai,et al.  Endoscopic sphincterotomy plus balloon dilation versus endoscopic sphincterotomy for choledocholithiasis: A meta‐analysis , 2013, Journal of gastroenterology and hepatology.

[162]  A. Chak,et al.  Does Rectal Indomethacin Eliminate the Need for Prophylactic Pancreatic Stent Placement in Patients Undergoing High-Risk ERCP? Post hoc Efficacy and Cost-Benefit Analyses Using Prospective Clinical Trial Data , 2013, The American Journal of Gastroenterology.

[163]  R. Conigliaro,et al.  Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial , 2013, Surgical Endoscopy.

[164]  S. Shin,et al.  Endoscopic large-balloon dilation alone versus endoscopic sphincterotomy plus large-balloon dilation for the treatment of large bile duct stones , 2013, BMC Gastroenterology.

[165]  John A. Windsor,et al.  Determinant-Based Classification of Acute Pancreatitis Severity: An International Multidisciplinary Consultation , 2012, Annals of surgery.

[166]  X. Zou,et al.  Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. , 2012, Gastrointestinal endoscopy.

[167]  Colin D Johnson,et al.  Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus , 2012, Gut.

[168]  Richard S. Kwon,et al.  A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. , 2012, The New England journal of medicine.

[169]  J. Damilakis,et al.  Radiation protection in digestive endoscopy: European Society of Digestive Endoscopy (ESGE) Guideline , 2012, Endoscopy.

[170]  C. Hassan,et al.  European Society of Gastrointestinal Endoscopy (ESGE) Guideline Development Policy , 2012, Endoscopy.

[171]  C. Ponsioen,et al.  The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluation , 2012, Scandinavian journal of gastroenterology.

[172]  Chung-Wook Chung,et al.  Is High-Dose Nafamostat Mesilate Effective for the Prevention of Post-ERCP Pancreatitis, Especially in High-Risk Patients? , 2011, Pancreas.

[173]  M. Hong,et al.  Using the 4-hour Post-ERCP amylase level to predict post-ERCP pancreatitis. , 2011, JOP : Journal of the pancreas.

[174]  Jun-bo Qian,et al.  Prevention of post‐endoscopic retrograde cholangiopancreatography pancreatitis by epinephrine sprayed on the papilla , 2011, Journal of gastroenterology and hepatology.

[175]  S. Sherman,et al.  Acute pancreatitis after removal of retained prophylactic pancreatic stents. , 2011, Gastrointestinal endoscopy.

[176]  R. Chuttani,et al.  A prospective assessment of sedation-related adverse events and patient and endoscopist satisfaction in ERCP with anesthesiologist-administered sedation. , 2011, Gastrointestinal endoscopy.

[177]  Richard S. Kwon,et al.  Prophylactic 5-Fr pancreatic duct stents are superior to 3-Fr stents: a randomized controlled trial. , 2011, Endoscopy.

[178]  M. Stringer,et al.  The arterial supply of the major duodenal papilla and its relevance to endoscopic sphincterotomy , 2011, Endoscopy.

[179]  W. Domschke,et al.  Post-ERCP pancreatitis in 2364 ERCP procedures: is intraductal ultrasonography another risk factor? , 2011, Endoscopy.

[180]  G. Lehman,et al.  Nafamostat Mesilate for Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Prospective, Randomized, Double-Blind, Controlled Trial , 2011, Pancreas.

[181]  N. Fukami,et al.  ERCP with cholangiopancreatoscopy may be associated with higher rates of complications than ERCP alone: a single-center experience. , 2011, Gastrointestinal endoscopy.

[182]  Mohamed O. Othman,et al.  Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. , 2011, Gastrointestinal endoscopy.

[183]  M. Brand,et al.  Antibiotic prophylaxis for patients undergoing elective endoscopic retrograde cholangiopancreatography. , 2010, The Cochrane database of systematic reviews.

[184]  Zhi‐Feng Zhang,et al.  Preventive effect of ulinastatin and gabexate mesylate on post-endoscopic retrograde cholangiopancreatography pancreatitis. , 2010, Chinese medical journal.

[185]  M. Manns,et al.  Routine bile collection for microbiological analysis during cholangiography and its impact on the management of cholangitis. , 2010, Gastrointestinal endoscopy.

[186]  A. Mariani,et al.  Risk Factors for Post-ERCP Pancreatitis in High- and Low-Volume Centers and Among Expert and Non-Expert Operators: A Prospective Multicenter Study , 2010, The American Journal of Gastroenterology.

[187]  Chun-Hui Wang,et al.  A meta-analysis for the effect of prophylactic GTN on the incidence of post-ERCP pancreatitis and on the successful rate of cannulation of bile ducts , 2010, BMC gastroenterology.

[188]  J. Rey,et al.  European Society of Gastrointestinal Endoscopy (ESGE) guideline: the use of electrosurgical units , 2010, Endoscopy.

[189]  N. Fujita,et al.  Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial , 2010, Journal of Gastroenterology.

[190]  M. Freeman,et al.  A Comparison of the Consensus and Clinical Definitions of Pancreatitis With a Proposal to Redefine Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis , 2010, Pancreas.

[191]  T. Fukui,et al.  Meta-analysis: somatostatin or its long-acting analogue, octreotide, for prophylaxis against post-ERCP pancreatitis , 2010, Journal of Gastroenterology.

[192]  G. Costamagna,et al.  Endoscopic hemostasis with fibrin glue for refractory postsphincterotomy and postpapillectomy bleeding. , 2010, Gastrointestinal endoscopy.

[193]  J. Kountouras,et al.  Endoscopic Hemostasis Using Monopolar Coagulation for Postendoscopic Sphincterotomy Bleeding Refractory to Injection Treatment , 2010, Surgical laparoscopy, endoscopy & percutaneous techniques.

[194]  F. Bazzoli,et al.  Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. , 2010, Endoscopy.

[195]  B. Petersen,et al.  A lexicon for endoscopic adverse events: report of an ASGE workshop. , 2010, Gastrointestinal endoscopy.

[196]  Jui-Hsiang Tang,et al.  Treating delayed endoscopic sphincterotomy-induced bleeding: epinephrine injection with or without thermotherapy. , 2009, World journal of gastroenterology.

[197]  Y. Bai,et al.  Glyceryl trinitrate for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2009, Endoscopy.

[198]  L. Madácsy,et al.  Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series , 2009, Surgical Endoscopy.

[199]  Joseph Romagnuolo,et al.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years. , 2009, Gastrointestinal endoscopy.

[200]  Y. Zhang,et al.  Meta‐analysis: octreotide prevents post‐ERCP pancreatitis, but only at sufficient doses , 2009, Alimentary pharmacology & therapeutics.

[201]  P. Andersen,et al.  Meta‐analysis: nitroglycerin for prevention of post‐ERCP pancreatitis , 2009, Alimentary pharmacology & therapeutics.

[202]  G. Kim,et al.  Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis. , 2009, Gastrointestinal endoscopy.

[203]  H. Dai,et al.  Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. , 2009, Hepatobiliary & pancreatic diseases international : HBPD INT.

[204]  K. Uchida,et al.  Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis , 2009, Journal of Gastroenterology.

[205]  F. Liu,et al.  Risk Factors for ERCP-Related Complications: A Prospective Multicenter Study , 2009, The American Journal of Gastroenterology.

[206]  P. Hsu,et al.  Effect of Somatostatin in the Prevention of Pancreatic Complications After Endoscopic Retrograde Cholangiopancreatography , 2008, Journal of the Chinese Medical Association : JCMA.

[207]  F. Gao,et al.  Prophylactic Antibiotics Cannot Prevent Endoscopic Retrograde Cholangiopancreatography-Induced Cholangitis: A Meta-Analysis , 2008, Pancreas.

[208]  M. Gershwin,et al.  Stevens-Johnson syndrome and toxic epidermal necrolysis. , 2008, Autoimmunity reviews.

[209]  M. Zheng,et al.  Gabexate mesylate in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review and meta-analysis update. , 2008, Current therapeutic research, clinical and experimental.

[210]  T. Barrioz,et al.  Intravenous nitroglycerin for prevention of pancreatitis after therapeutic endoscopic retrograde cholangiography: a randomized, double-blind, placebo-controlled multicenter trial , 2008, Endoscopy.

[211]  P. Higgins,et al.  A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis , 2008, Gut.

[212]  J. Lee,et al.  Infection after ERCP, and antibiotic prophylaxis: a sequential quality-improvement approach over 11 years. , 2008, Gastrointestinal endoscopy.

[213]  T. Baron,et al.  Post-Sphincterotomy Bleeding: Who, What, When, and How , 2007, The American Journal of Gastroenterology.

[214]  P. Williamson,et al.  Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study , 2007, Endoscopy.

[215]  Angelo Andriulli,et al.  Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies , 2007, The American Journal of Gastroenterology.

[216]  A. Kapadia,et al.  Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. , 2007, Gastrointestinal endoscopy.

[217]  N. Fujita,et al.  Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure. , 2007, World journal of gastroenterology.

[218]  J. Trotter,et al.  Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease , 2007, Alimentary pharmacology & therapeutics.

[219]  J. Kountouras,et al.  A novel technique of injection treatment for endoscopic sphincterotomy-induced hemorrhage. , 2007, Endoscopy.

[220]  A. Kiss,et al.  Somatostatin and gabexate for post‐endoscopic retrograde cholangiopancreatography pancreatitis prevention: Meta‐analysis of randomized placebo‐controlled trials , 2007, Journal of gastroenterology and hepatology.

[221]  M. Sivak,et al.  Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. , 2007, Gastrointestinal endoscopy.

[222]  A. Andriulli,et al.  Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. , 2007, Gastrointestinal Endoscopy.

[223]  G. Kitis,et al.  The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis. , 2007, Hepato-gastroenterology.

[224]  Yongping Chen,et al.  Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials , 2007, BMC gastroenterology.

[225]  P. Cotton Analysis of 59 ERCP lawsuits; mainly about indications. , 2006, Gastrointestinal endoscopy.

[226]  M'hamed Temkit,et al.  Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study , 2006, The American Journal of Gastroenterology.

[227]  C. Ferguson,et al.  Non-variceal upper gastrointestinal bleeding , 2006, The Ulster medical journal.

[228]  J. Segal,et al.  Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review , 2005, Transfusion.

[229]  G. Sakorafas,et al.  Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial , 2004, Journal of gastroenterology and hepatology.

[230]  K. Mönkemüller,et al.  Patterns of Bleeding after Endoscopic Sphincterotomy, the Subsequent Risk of Bleeding, and the Role of Epinephrine Injection , 2004, American Journal of Gastroenterology.

[231]  S. Fan,et al.  Title Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures : A randomised controlled trial , 2003 .

[232]  A. Mariani,et al.  Risk Factors for Pancreatitis Following Endoscopic Retrograde Cholangiopancreatography: A Meta-Analysis , 2003, Endoscopy.

[233]  S. Ladas,et al.  Recommendations of the ESGE Workshop on Informed Consent for Digestive Endoscopy , 2003, Endoscopy.

[234]  R. Enns,et al.  ERCP-Related Perforations: Risk Factors and Management , 2002, Endoscopy.

[235]  Steven R Deitcher,et al.  Interpretation of the international normalised ratio in patients with liver disease , 2002, The Lancet.

[236]  S. Sengupta,et al.  Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4‐h post procedure amylase level , 2001, Journal of gastroenterology and hepatology.

[237]  C. Crosta,et al.  Complications of diagnostic and therapeutic ERCP: a prospective multicenter study , 2001, American Journal of Gastroenterology.

[238]  A. Harris,et al.  Meta-analysis of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography (ERCP). , 1999, Endoscopy.

[239]  J. Hoekstra,et al.  Abnormal clotting parameters before therapeutic ERCP: do they predict major bleeding? , 1999, European journal of gastroenterology & hepatology.

[240]  D. Seo,et al.  Endoscopic hemostasis in sphincterotomy-induced hemorrhage: its efficacy and safety. , 1999, Endoscopy.

[241]  P. Testoni,et al.  Serum amylase measured four hours after endoscopic sphincterotomy is a reliable predictor of postprocedure pancreatitis , 1999, American Journal of Gastroenterology.

[242]  R. Trap,et al.  Severe and fatal complications after diagnostic and therapeutic ERCP: a prospective series of claims to insurance covering public hospitals. , 1999, Endoscopy.

[243]  J. Devière,et al.  A New Method of Achieving Deep Cannulation of the Common Bile Duct During Endoscopic Retrograde Cholangiopancreatography , 1998, Endoscopy.

[244]  P. Fina,et al.  Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. , 1998, Gastrointestinal endoscopy.

[245]  R. Selby,et al.  Management of Duodenal Perforation After Endoscopic Retrograde Cholangiopancreatography and Sphincterotomy , 1998, Annals of surgery.

[246]  J. Llach,et al.  Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study. , 1998, Gastrointestinal endoscopy.

[247]  T. Zágoni,et al.  Complications of endoscopic biliary sphincterotomy. , 1997, The New England journal of medicine.

[248]  S. Sherman,et al.  Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes. , 1996, The American journal of gastroenterology.

[249]  M. Kovacs,et al.  Assessment of the Validity of the INR System for Patients with Liver Impairment , 1994, Thrombosis and Haemostasis.

[250]  J. Devière,et al.  Risk factors for septicemia following endoscopic biliary stenting. , 1991, Gastroenterology.

[251]  C Liguory,et al.  Endoscopic sphincterotomy complications and their management: an attempt at consensus. , 1991, Gastrointestinal endoscopy.

[252]  M. Classen,et al.  Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. , 1989, The New England journal of medicine.

[253]  D. Moura,et al.  Pancreatic Stent Placement for Prevention of Post-ERCP Pancreatitis in High-Risk Patients: A Systematic Review and Meta-Analysis , 2019 .

[254]  C. Fabbri,et al.  A multicenter randomized trial comparing the use of touch versus no-touch guidewire technique for deep biliary cannulation: the TNT study. , 2018, Gastrointestinal endoscopy.

[255]  M. Pavesi,et al.  Adverse Events and Acute Chronic Liver Failure in Patients With Cirrhosis Undergoing Endoscopic Retrograde Cholangiopancreatography: A Multicenter Matched-Cohort Study , 2018, The American Journal of Gastroenterology.

[256]  B. Thomson,et al.  Predicting post‐endoscopic retrograde cholangiopancreatography pancreatitis using the 4‐h serum lipase level , 2018, ANZ journal of surgery.

[257]  Eun Hye Kim,et al.  Comparative efficacy of various endoscopic techniques for the treatment of common bile duct stones: a network meta-analysis. , 2018, Gastrointestinal endoscopy.

[258]  Zhi‐Feng Zhang,et al.  Aggressive Hydration With Lactated Ringer Solution in Prevention of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: A Meta-analysis of Randomized Controlled Trials , 2017, Journal of clinical gastroenterology.

[259]  Sumant Inamdar,et al.  Rectal indomethacin is protective against post-ERCP pancreatitis in high-risk patients but not average-risk patients: a systematic review and meta-analysis. , 2017, Gastrointestinal endoscopy.

[260]  I. Song,et al.  Vigorous Periprocedural Hydration With Lactated Ringer's Solution Reduces the Risk of Pancreatitis After Retrograde Cholangiopancreatography in Hospitalized Patients , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[261]  A. Dwivedi,et al.  A prospective study of the risk of bacteremia in directed cholangioscopic examination of the common bile duct. , 2016, Gastrointestinal endoscopy.

[262]  Vikesh K. Singh,et al.  Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. , 2015, Gastrointestinal endoscopy.

[263]  S. Moreea,et al.  Use of the haemostatic agent TC-325 in the treatment of bleeding secondary to endoscopic retrograde cholangiopancreatography sphincterotomy. , 2015, QJM : monthly journal of the Association of Physicians.

[264]  J. Kountouras,et al.  Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist , 2014, Annals of gastroenterology.

[265]  A. Norouzi,et al.  The effect of adding gentamicin to contrast media for prevention of cholangitis after biliary stenting for non-calculous biliary obstruction, a randomized controlled trial , 2012, Indian Journal of Gastroenterology.

[266]  A. Kanno,et al.  Risk factors for post-ERCP pancreatitis in high risk patients who have undergone prophylactic pancreatic duct stenting: a multicenter retrospective study. , 2011, Internal medicine.

[267]  Jian-ting Cai,et al.  Nitroglycerin in the Prevention of Post-ERCP Pancreatitis: A Meta-Analysis , 2008, Digestive Diseases and Sciences.

[268]  A. Andriulli,et al.  Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. , 2000, Gastrointestinal endoscopy.

[269]  J. Bordas,et al.  Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy. , 1988, Hormone research.